PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia.\', \'Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia.\', \'Ken Saras General Hospital, Semarang, Indonesia.\', \'Balaraja General Hospital, Tangerang, Indonesia.\', \'Department of Cardiology and Vascular Medicine, Siloam Hospitals Lippo Village, Tangerang, Indonesia. Antonia.lukito@uph.edu.\', \'Department of Internal Medicine, Faculty of Medicine, Udayana University, Sanglah Teaching Hospital, Denpasar- Bali, Indonesia.\', \'Division of Gastroentero-Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Udayana, Denpasar, Indonesia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s43440-021-00263-x
?:doi
?:hasPublicationType
?:journal
  • Pharmacological reports : PR
is ?:pmid of
?:pmid
?:pmid
  • 33840053
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all